MedPath

武汉法玛星制药有限公司

Ownership
-
Established
2019-08-13
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

NMPA:2

Drug Approvals

Loxoprofen Sodium Cataplasms

Product Name
洛索洛芬钠凝胶贴膏
Approval Number
国药准字H20253634
Approval Date
Mar 18, 2025
NMPA

Flurbiprofen Cataplasms

Product Name
氟比洛芬凝胶贴膏
Approval Number
国药准字H20253234
Approval Date
Jan 24, 2025
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.